Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Lefebvre

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Revue Medicale De Liege|April 1, 1997
[Presbycusis]P P Lefebvre
Acta Oto-Laryngologica|October 31, 2002
Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case reportH Staecker, P P Lefebvre
Revue Medicale De Liege|December 10, 1999
[Middle ear ventilation tubes: present indications and prospects]P P Lefebvre, L Edzang
Mediators of Inflammation|July 19, 2011
Modulation of NK cell autocrine-induced eosinophil chemotaxis by interleukin-15 and vitamin D(3): a possible NK-eosinophil crosstalk via IL-8 in the pathophysiology of allergic rhinitisA E El-Shazly, P P Lefebvre
Acta Oto-Rhino-Laryngologica Belgica|January 1, 1997
Non-Hodgkin's lymphoma of the paranasal sinuses. Report of two casesP P Lefebvre, S Tombu, J P Demanez
Brain Research. Brain Research Reviews|August 6, 2000
Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 geneP P Lefebvre, T R Van De Water
Audiology & Neuro-Otology|September 22, 2006
Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing lossF Van Wijk, H Staecker, E Keithley, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challengeA E El-Shazly, M Henket, P P Lefebvre, et al.
Brain Research|July 1, 1984
Cerebellar macroneurons in serum-free cultures: evidence for intrinsic neuronotrophic and neuronotoxic activitiesM P Grau-Wagemans, I Selak, P P Lefebvre, et al.
Current Pharmaceutical Design|July 20, 2005
Molecular pathways involved in apoptotic cell death in the injured cochlea: cues to novel therapeutic strategiesF Lallemend, P P Lefebvre, G Hans, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Revue Medicale De Liege|April 1, 1997
[Presbycusis]P P Lefebvre
Acta Oto-Laryngologica|October 31, 2002
Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case reportH Staecker, P P Lefebvre
Revue Medicale De Liege|December 10, 1999
[Middle ear ventilation tubes: present indications and prospects]P P Lefebvre, L Edzang
Mediators of Inflammation|July 19, 2011
Modulation of NK cell autocrine-induced eosinophil chemotaxis by interleukin-15 and vitamin D(3): a possible NK-eosinophil crosstalk via IL-8 in the pathophysiology of allergic rhinitisA E El-Shazly, P P Lefebvre
Acta Oto-Rhino-Laryngologica Belgica|January 1, 1997
Non-Hodgkin's lymphoma of the paranasal sinuses. Report of two casesP P Lefebvre, S Tombu, J P Demanez
Brain Research. Brain Research Reviews|August 6, 2000
Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 geneP P Lefebvre, T R Van De Water
Audiology & Neuro-Otology|September 22, 2006
Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing lossF Van Wijk, H Staecker, E Keithley, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challengeA E El-Shazly, M Henket, P P Lefebvre, et al.
Brain Research|July 1, 1984
Cerebellar macroneurons in serum-free cultures: evidence for intrinsic neuronotrophic and neuronotoxic activitiesM P Grau-Wagemans, I Selak, P P Lefebvre, et al.
Current Pharmaceutical Design|July 20, 2005
Molecular pathways involved in apoptotic cell death in the injured cochlea: cues to novel therapeutic strategiesF Lallemend, P P Lefebvre, G Hans, et al.
Pageof 6